Catalyst Wire Dossier Catalyst Wire Dossier

nelotanserin

nelotanserin · Axovant Sciences Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for nelotanserin, covering 2018-01-18 to 2020-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD) [Phase 2]

See pricing